Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.
Chaudhry HM, Mauermann ML, Rajkumar SV.
Mayo Clin Proc. 2017 May;92(5):838-850. doi: 10.1016/j.mayocp.2017.02.003.
PMID:28473042
Monoclonal Gammopathy of Undetermined Significance.
Gonsalves WI, Rajkumar SV.
Ann Intern Med. 2022 Dec;175(12):ITC177-ITC192. doi: 10.7326/AITC202212200. Epub 2022 Dec 13.
PMID:36508741
Monoclonal gammopathy of cutaneous significance.
Berk-Krauss J, Rosenbach M.
J Am Acad Dermatol. 2025 Oct;93(4):1042-1048. doi: 10.1016/j.jaad.2025.05.1432. Epub 2025 Jun 2.
PMID:40466947
Cutaneous manifestations of monoclonal gammopathy.
Claveau JS, Wetter DA, Kumar S.
Blood Cancer J. 2022 Apr 11;12(4):58. doi: 10.1038/s41408-022-00661-1.
PMID:35411042
Monoclonal gammopathy of uncertain significance.
Alejo E, Puertas B, Mateos MV.
Med Clin (Barc). 2023 Sep 8;161(5):217-224. doi: 10.1016/j.medcli.2023.05.006. Epub 2023 Jun 15.
PMID:37330390
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, Dispenzieri A, Song KW, Kyle RA; International Kidney and Monoclonal Gammopathy Research Group.
Blood. 2012 Nov 22;120(22):4292-5. doi: 10.1182/blood-2012-07-445304. Epub 2012 Oct 9.
PMID:23047823
Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment.
Karam S, Haidous M, Dalle IA, Dendooven A, Moukalled N, Van Craenenbroeck A, Bazarbachi A, Sprangers B.